Ftse Mib
37.098,81
-0,06%
DAX
21.901,53
-0,05%
S&P 500
6.095,42
0,19%
NASDAQ
19.791,99
0,00%
Bitcoin
99.878,01
3,42%
Pepperstone
Advertisement
Registration Strip Icon for discussion Registrati per interagire nei nostri forum attivi per discutere con investitori con idee simili.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Adaptive Biotechnologies Corporation (ADPT) Adaptive Biotechnologies Corporation (ADPT) Notizie

Adaptive Biotechnologies Corporation

ADPT
8,01
0,00 (0,00%)
Pre Mercato
Ultimo aggiornamento: 15:27:10
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
05/2/202522:05GLOBEAdaptive Biotechnologies to Participate in Upcoming Investor..
22/1/202522:05GLOBEAdaptive Biotechnologies to Report Fourth Quarter and Full..
14/1/202513:30GLOBEAdaptive Biotechnologies and NeoGenomics Partner to Expand..
07/1/202513:30GLOBEAdaptive Biotechnologies Announces Clinical Lab Fee Schedule..
02/1/202522:05GLOBEAdaptive Biotechnologies to Present at the 43rd Annual J.P...
08/12/202400:30GLOBEAdaptive Biotechnologies Announces New Data at the 66th ASH..
03/12/202413:30GLOBEAdaptive Biotechnologies Announces Over 65 Abstracts..
20/11/202400:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/11/202422:30EDGAR2Form SC 13G - Statement of Beneficial Ownership by Certain..
08/11/202421:15EDGAR2Form SC 13G - Statement of Beneficial Ownership by Certain..
07/11/202422:30EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/11/202422:15EDGAR2Form 8-K - Current report
07/11/202422:05GLOBEAdaptive Biotechnologies Reports Third Quarter 2024..
07/11/202413:30GLOBEAdaptive Biotechnologies Receives Expanded Medicare Coverage..
10/10/202423:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/10/202422:05GLOBEAdaptive Biotechnologies to Report Third Quarter 2024..
29/8/202413:30GLOBEAdaptive Announces IVDR Certification for clonoSEQ® in..
23/8/202422:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/8/202422:18EDGAR2Form 144 - Report of proposed sale of securities
22/8/202422:03GLOBEAdaptive Biotechnologies to Participate in the Morgan..
01/8/202422:30EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
01/8/202422:15EDGAR2Form 8-K - Current report
01/8/202422:05GLOBEAdaptive Biotechnologies Reports Second Quarter 2024..
11/7/202422:05GLOBEAdaptive Biotechnologies to Report Second Quarter 2024..
11/6/202422:15EDGAR2Form 8-K - Current report
31/5/202413:30GLOBEAdaptive Biotechnologies Announces Data Supporting the..
29/5/202422:05GLOBEAdaptive Biotechnologies to Participate in the Goldman Sachs..
24/5/202418:01EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
18/5/202400:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/5/202422:30EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/5/202422:15EDGAR2Form 8-K - Current report
07/5/202422:05GLOBEAdaptive Biotechnologies Reports First Quarter 2024..
17/4/202422:05GLOBEAdaptive Biotechnologies to Report First Quarter 2024..
02/4/202422:05GLOBEAdaptive Biotechnologies Provides Strategic Review Update..
27/3/202413:30GLOBEAdaptive Biotechnologies to Hold a Business Update..
07/3/202401:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/3/202401:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/3/202401:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/3/202401:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/3/202401:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/3/202401:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/3/202401:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/3/202401:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/3/202401:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/3/202401:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/3/202401:38EDGAR2Form 3 - Initial statement of beneficial ownership of..
22/2/202422:05GLOBEAdaptive Biotechnologies to Present at the TD Cowen 44th..
14/2/202422:15EDGAR2Form 8-K - Current report
14/2/202422:05GLOBEAdaptive Biotechnologies Reports Fourth Quarter and Full..
Apertura: Min: Max:
Chiusura: 8,01

La tua Cronologia

NASDAQ
ADPT
Adaptive Biotechnologies
DBI
I2RB
DAXsubsector Retail Food...
BIT
UC3X8N
Unicredit Bank
BIT
P12350
Bnp Paribas Issuance
BIT
UC4SU7
Unicredit Bank
BIT
P1HZG0
BNP Paribas Issuance
BIT
S31375
Societe Generale Effekten
BIT
UC4682
Unicredit Bank
BIT
W8USY9
UBS
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network

Rimuovi gli annunci

Iscriviti per un'esperienza senza pubblicità

Nessuna pubblicità

Prova adesso

Conserva gli annunci